| 11168150 |
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA |
Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Su Yan, Jingyi Xiang +1 more |
2021-11-09 |
| 11155615 |
Anti-ROR1 antibodies |
Brian Wong, Emma Masteller, Yiyang Xu, Hong Liu, Su Yan +2 more |
2021-10-26 |
| 11136392 |
PD-1 immune modulating agents |
Renier J. Brentjens, Hollie J. Jackson |
2021-10-05 |
| 11117964 |
Anti-KIR3DL1 antibodies |
Katharine Hsu, Nai-Kong V. Cheung, Su Yan, Yiyang Xu, Jingyi Xiang |
2021-09-14 |
| 11059891 |
Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof |
Renier J. Brentjens, Eric Smith |
2021-07-13 |
| 11034759 |
Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof |
Deborah Lee Zimmerman, Gregory Martin Harrowe, Kirston E. Koths, William Michael Kavanaugh, Li Long +2 more |
2021-06-15 |
| 11000549 |
Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof |
Renier J. Brentjens, Eric Smith |
2021-05-11 |
| 10947314 |
Antibodies targeting b-cell maturation antigen and methods of use |
Renier J. Brentjens, Eric Smith |
2021-03-16 |
| 10918665 |
Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof |
Renier J. Brentjens, Eric Smith |
2021-02-16 |
| 10913796 |
Antibodies targeting Fc receptor-like 5 and methods of use |
Renier J. Brentjens, Eric Smith |
2021-02-09 |
| 10906956 |
Methods of treatments using chimeric antigen receptors targeting G-protein coupled receptor |
Renier J. Brentjens, Eric Smith |
2021-02-02 |